Avantor Inc (AVTR) is not a strong buy for a beginner, long-term investor at this time. The company is facing significant challenges, including declining financial performance, bearish technical indicators, and negative sentiment from analysts. While there are some positive catalysts, such as the 'Revival' program and stable demand for lab consumables, these are outweighed by the company's struggles with growth and profitability. It is better to wait for clearer signs of recovery before investing.
The technical indicators for AVTR are bearish. The MACD is slightly positive but expanding, while the RSI is neutral at 37.585. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5. The stock is trading near its pivot level of 7.706, with support at 7.448 and resistance at 7.964. Overall, there is no strong bullish momentum.

Circumference Group recently acquired 305,000 shares, reflecting some confidence in the company. Avantor is implementing a 'Revival' program to address execution and cost structure issues, and there is stable demand for lab consumables.
Analysts have downgraded the stock, citing share losses, lack of investment, and management concerns. The stock has also declined 54% over the past year.
Avantor's Q4 2025 financials showed a revenue decline of -1.36% YoY to $1.66 billion, net income dropped -89.53% YoY to $52.4 million, and EPS fell -89.04% YoY to $0.08. Gross margin also declined by -5.63% YoY to 31.49%.
Analyst sentiment is negative. Barclays downgraded the stock to Underweight with a price target of $8.50, citing share losses and management concerns. Other firms, including Morgan Stanley, Citi, and Jefferies, have lowered their price targets, with most ratings being Neutral or Underperform.